Research programme: cancer therapeutics - Riverway Discoveries
Alternative Names: Research programme: cancer therapeutics - Riverway Discoveries/Dana-Farber Cancer Institute/DeerfieldLatest Information Update: 10 Feb 2021
At a glance
- Originator Dana-Farber Cancer Institute
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer